The trades that built the Blue Jays roster: Where are they now?

July 30th, 2015

David Price was the type of deadline target that was supposed to be too big a name for the Toronto Blue Jays. Even so soon after the Tulowitzki addition, though, landing one of baseball’s best starting pitchers still sounded too good to be true.

Now that the emotions of this past offseason have settled, it’s easy to see that the Blue Jays got what they wanted in Price: one all-or-nothing shot at the World Series with a bonafide ace atop their rotation. Beyond that? Let the chips fall as they may.

Those chips fell with price landing within the division, unfortunately, where he’s now finding his old self with his ERA dropping to 4.64 through 18 starts. In his time with Toronto he gave the Blue Jays 11 starts and a 2.30 ERA, but his playoff outings didn’t go as smoothly.

Daniel Norris has overcome a great deal since the trade. He announced after the season that a cancerous growth had been discovered on his thyroid, one that has since been surgically removed.

After looking promising in eight starts down the stretch for Detroit in 2015 (3.68 ERA), Norris is still waiting for it to click this season. The MLB-level competition hasn’t gone well, and he still holds a 4.68 ERA in 11 triple-A starts. He was recently placed on the disabled list with an oblique strain.

The 25-year-old Boyd had been roughed up over 29.1 MLB innings this season (6.44 ERA). Triple-A Toledo has been an entirely different story, however, where he’s cruised to a 2.25 ERA over 11 starts. Making that jump from upper-minors success to the major league level continues to be Boyd’s challenge.

Left-hander Jairo Labourt is currently pitching with Advanced-A Lakeland, where his ERA sits up at 6.87 over 12 starts and five relief appearances. MLB Pipeline lists him as Detroit’s number 10 prospect

Norris may still need several seasons to reach his full potential, though if he does, that ceiling remains immense.

Last but not least, we look at some smaller deals and their value:

Next: The extras: 5 minor deals since the Price blockbuster